New User:
-or-
Username:
Password:
Forgot your password?
News Breaks
08:52 EDTITMN
theflyonthewall.com: Intermune submits Pirfenidone NDA to FDA
InterMune has submitted an electronic New Drug Application with the FDA seeking approval to market pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis. Pirfenidone has been granted Orphan Drug and Fast Track designation by the FDA, and also has been granted Orphan Drug status in Europe. :theflyonthewall.com



News For ITMN From The Last 14 Days
Check below for free stories on ITMN the last two weeks.
There are 8 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
February 4, 2010
07:55 EDTITMN
theflyonthewall.com: InterMune risk/reward not attractive into upcoming events, says Jefferies
Jefferies believes the risk/reward profile on InterMune shares is not attractive into the FDA Committee panel for pirfenidone scheduled for March 9, 2010. The firm expects a mixed panel outcome and reiterates an Underperform rating on the stock. :theflyonthewall.com

February 3, 2010
09:53 EDTITMN
theflyonthewall.com: Leerink hosts an analyst Biotechnology/Industry conference call

Subscribe for More Information :theflyonthewall.com

February 2, 2010
09:48 EDTITMN
theflyonthewall.com: Three stocks with IV rise on Feb 1; ITMN TLB MDVN

Subscribe for More Information :theflyonthewall.com

February 1, 2010
13:17 EDTITMN
theflyonthewall.com: Intermune options active on volatility increase into FDA meeting

Subscribe for More Information :theflyonthewall.com
10:06 EDTITMN
theflyonthewall.com: InterMune says FDA committee to discuss drug on March 9, 2010
InterMune announced that the FDA's Pulmonary-Allergy Drugs Advisory Committee is scheduled to discuss the company's New Drug Application for pirfenidone on March 9, 2010. Pirfenidone is InterMune's investigational drug candidate for the treatment of patients with idiopathic pulmonary fibrosis. :theflyonthewall.com
09:51 EDTITMN
theflyonthewall.com: Intermune March volatility at 174, April at 16 on active volume into meeting

Subscribe for More Information :theflyonthewall.com
09:44 EDTITMN
theflyonthewall.com: Active equity option families in first 10-minutes
Active equity option families in first 10-minutes of trading according to Track Data are: C ITMN AAPL JPM. :theflyonthewall.com

January 28, 2010
05:33 EDTITMN
theflyonthewall.com: Warburg Pincus increases stake in Intermune to 17.7% from 15.8%
:theflyonthewall.com